Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: J Low Genit Tract Dis. 2013 Apr;17(5 0 1):S28–S35. doi: 10.1097/LGT.0b013e318285423c

Figure 2.

Figure 2

Cumulative risks of CIN2+ (left panel), CIN3+ (middle panel), and cancer (right panel), among women aged 30–64, by baseline test results of HPV+/ASC-US, LSIL alone (regardless of HPV test result), Pap-negative (Pap−) alone (regardless of HPV test result) and HPV-negative/Pap-negative. Note that the y-axes have different scales for different panels.